EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose–Response Meta‐Analysis

Liusong Shen iD, Fanqiang Meng, Qiao Jiang, Junzhi Sheng, Haoran Feng, Yuqing Wang, Huizhong Long, Dongxing Xie, Tuo Yang, Xiang Ding iD, Yilin Xiong

International Journal of Rheumatic Diseases · 2025-01 · 28 (1)

DOI: 10.1111/1756-185x.70013 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 02.01.2025. Verfasst von Liusong Shen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Bone Density, Uric Acid, Osteoporosis, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Central South University Innovation-Driven Research Programme, Fundamental Research Funds for Central Universities of the Central South University, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Serum uric acid (SUA) may play positive roles in diseases associated with oxidative stress, such as osteoporosis (OP). Nevertheless, the specific impact of SUA levels on both bone mineral density (BMD) and the risk of OP remains uncertain. Considering such information crucial for clinicians when making decisions about urate‐lowering therapy (ULT), we sought to fill this gap by conducting dose–response meta‐analyses.

Methods

PubMed, EMBASE, and Cochrane Library were searched for studies that met the inclusion criteria. Pooled standardized mean difference (SMD) for BMDs and the odds ratio (OR) for OP between the highest and lowest SUA categories as well as the nonlinear dose–response relationships were estimated.

Results

Pooled SMDs indicate that participants in the highest category of SUA have greater BMDs at the lumbar spine (SMD = 0.37; 95% CI: 0.27, 0.46), femoral neck (SMD = 0.25; 95% CI: 0.21, 0.29), total hip (SMD = 0.34; 95% CI: 0.26, 0.42), and lower risk of OP (OR = 0.59, 95% CI: 0.52, 0.67) compared with the lowest. The nonlinear dose–response relationships were also observed. However, when the SUA level exceeded 6 mg/dL, the dose–response curve between SUA levels and the risk of OP tended to be flattened.

Conclusion

Nonlinear dose–response relationships were found that higher SUA levels are associated with greater BMDs and lower risk of OP. For patients receiving ULT, maintaining SUA level at around 6 mg/dL may be appropriate from the perspective of bone metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityUric AcidOsteoporosisBiomarkersHumansRisk FactorsRisk AssessmentFemaleMiddle AgedMaleAgedAdult

Stichwörter der Autor:innen

bone mineral densitydose–responseosteoporosisserum uric acid

Substanzen

Uric AcidBiomarkers

Autor:innen und Institutionen

  • Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Key Laboratory of Aging-Related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Liusong Shen, Xiang Ding

Förderung

  • Central South University Innovation-Driven Research Programme
  • Fundamental Research Funds for Central Universities of the Central South University
  • Science and Technology Program of Hunan Province
  • Key Research and Development Program of Hunan Province of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Shen, L., Meng, F., Jiang, Q., Sheng, J., Feng, H., Wang, Y., Long, H., Xie, D., Yang, T., Ding, X., & Xiong, Y. (2025). Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose–Response Meta‐Analysis. International Journal of Rheumatic Diseases, 28(1). https://doi.org/10.1111/1756-185x.70013

Vancouver

Shen L, Meng F, Jiang Q, Sheng J, Feng H, Wang Y, et al. Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose–Response Meta‐Analysis. International Journal of Rheumatic Diseases. 2025;28(1). doi:10.1111/1756-185x.70013

BibTeX
@article{Shen2025,
  author = {Shen, Liusong and Meng, Fanqiang and Jiang, Qiao and Sheng, Junzhi and Feng, Haoran and Wang, Yuqing and Long, Huizhong and Xie, Dongxing and Yang, Tuo and Ding, Xiang and Xiong, Yilin},
  title = {Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose–Response Meta‐Analysis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  volume = {28},
  number = {1},
  doi = {10.1111/1756-185x.70013}
}
Kostenlos starten →